ESM1 was identified as a potential serum marker for the early detection of colorectal cancer, participating in cell survival, invasion, and EMT through Akt-dependent inhibition of NF-κB/IκB pathway [27]. This evidence concerns the gene ESM1 and colorectal cancer.